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Monday, February 4, 2013 265akinetics. The mechanism by which the eag domain regulates gating remains un-
clear. Recent evidence suggests the intracellular loop between the S4 and S5
transmembrane domains (S4-S5 linker) may be important in regulating both ac-
tivation and deactivation, and that modulation of gating by the eag domain may
act via the S4-S5 linker. Here we sought to investigate the role of the S4-S5
linker using site-directed mutagenesis and a combination of electrophysiology
and Fo¨rster Resonance Energy Transfer (FRET). We found that channels with
alanine mutations in the S4-S5 linker exhibited altered gating. All the S4-S5
mutant channels caused an acceleration of deactivation kinetics, except for
S543A which had significantly slowed deactivation. Co-expressing an eag do-
main gene fragment (N-eag) with S4-S5 mutant channels which additionally
lacked a native eag domain (Deag) failed to restore slow deactivation kinetics
to the mutant channels. FRET analysis revealed that eag domains tagged with
a CFP were in close proximity to each of the S4-S5 mutant channels tagged
with a Citrine. Replacement of the entire S4-S5 linker with alanines (hERG
[S4-S5]Ala) produced channels with altered gating, including fast deactivation
and a far left-shifted steady-state activation curve. Co-expression of hERG
Deag[S4-S5]Ala channels with N-eag did not alter channel gating; however,
FRET analysis revealed that N-eag was in close proximity to the mutant chan-
nels. Together, these findings suggest that an intact S4-S5 linker is necessary to
transduce eag domain-dependent regulation of gating, but it is not required for
the eag domain to bind to the channel.
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The hERG cardiac Kþ channel is characterized by unusually slow activation
and deactivation gating kinetics compared to Shaker-like voltage-gated Kþ
(Kv) channels. In Shaker-like Kv channels movement of the voltage sensor
upon depolarization is mechanically transduced by the a-helical S4-S5 linker
to S6 activation gate opening. Given the unique gating properties of hERG
channels, the details of voltage sensor coupling with the S6 activation gate
are of significant interest. We have recently shown that substitution of a glycine
residue (G546) within the S4-S5 linker with a leucine residue destabilizes the
closed state (left-shifts the V1/2 of activation by ~50 mV and accelerates the rate
of channel opening) and suggested that flexibility of the linker may be a key
determinant of the closed-open equilibrium in hERG channels. Here, we
have investigated this further by re-introducing glycine residues within the
S4-S5 linker (from position 539 to 552) in the G546L background to determine
whether flexibility introduced at different positions within the helix restores
WT-like gating. We found a cluster of sites in the N-terminal portion of the
S4-S5 linker (D540, R541, Y542, E544) that, when replaced with a glycine
residue, rescued the 50 mV shift caused by the G546L mutation restoring
a WT-like voltage dependence of activation. None of these mutations affected
the voltage dependence of activation in the WT background. All other muta-
tions tested did not rescue WT function and presented the destabilized closed
state phenotype that is characteristic of the G546L mutation. These results sug-
gest that flexibility of the N-terminal S4-S5 linker contributes to stabilization of
hERG channels in the closed state and that the native glycine, G546, affords
this flexibility in WT channels.
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In Shaker channels, the activation gate is formed at the bundle crossing by the
convergence of the inner S6 helices near a conserved proline-valine-proline
(PVP) motif, which introduces a kink in the helices that allows for electrome-
chanical coupling with voltage sensor motions via the S4-S5 linker. Human
ether-a-go-go related gene (hERG) channels lack the PVP motif and the loca-
tion of the intracellular pore gate and how it is coupled to S4 movement is less
clear. Here, we performed a proline scan of the inner S6 helix, from I655 to
Y667, to determine the position of the gate. The rationale was that proline-
induced S6 disruption would impede gate function when a proline was engi-
neered above, but not below, the native gate region. We discovered that
proximal substitutions (I655P-Q664P) impeded gate closure trapping channels
in the open state, while distal substitutions (R665P, L666P and Y667P) pre-
served wild type-like gating. That proline substitutions below Q664 preserved
channel gating, while residues above disrupted gate function, strongly suggests
that the position of the intracellular gate is formed at Q664. These data are con-
sistent with previous homology model-based predictions1. Interestingly, in
V659P channels the gate was trapped open, but upon strong hyperpolarizationchannels slowly activated into a distinct voltage-dependent open state, reminis-
cent of the well-studied hERG mutation, D540K. The presence of voltage-
dependent gating in this mutant suggests that the trapped open phenotype is
due to uncoupling of gate closure from voltage sensor gating, rather than an
immobilization of sensor movement. Moreover, the activation of V659P chan-
nels upon hyperpolarization suggests a ‘down’ configuration of the voltage
sensor that is distinct from that occupied at 80 mV and that leads to
hyperpolarization-activated pore opening, as in HCN channels.
1 Wynia-Smith et. al., J. Gen. Physiol. 132:507-520, 2008.
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Unlike many Kv channels, hERG channel activation and deactivation are slow
and are apparently limited by slow movement of the S4 voltage sensor. In fast-
activating Shaker channels, a putative gating charge transfer centre formed in
part by F290 has been proposed to interact with S4 charges (e.g. R1, K5) and,
thus, modulate voltage-dependent gating. F290 is conserved in hERG (F463),
but the relevant residues in the hERG S4 are reversed (K1, R5) and there is
an extra positive charge adjacent to R5 (K6). We have examined whether
hERG channels possess a transfer centre similar to that in Shaker and if these
S4 charge differences underlie slow gating in hERG channels. Of five hERG
F463 hydrophobic substitutions tested, only F463W and F463Y shifted the
G-V relationship to more depolarized potentials and dramatically (>20x)
slowed channel activation. With the S4 residue reversals (i.e. K1, R5) taken
into account, this closed state stabilization suggests a role for F463 that is sim-
ilar to that described for F290 in Shaker. Also consistent with results from
Shaker, the hERG K1R mutation left-shifted the G-V relationship and stabi-
lized the open state. In contrast to a predicted stabilization of the open state,
R5K caused a moderate right-shift of the G-V and closed-state stabilization. In-
triguingly, the neighbouring K6 residue was more important than R5 in hERG
voltage sensing, since K6R dramatically slowed and right-shifted activation.
Taken together, these data suggest a role for F463 in mediating the closed-
open equilibrium, similar to that proposed for F290 in Shaker channels. Fur-
thermore, the hERG channel open state appears to be stabilized by the unique
configuration of R5 and K6 side chains. Both charges play important roles, but
that of K6 appears more critical at stabilizing the activated state of the channel.
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hERG channels (human ether-a` -go-go related gene, Kv11.1) play an important
role conducting potassium ions in the cardiac delayed rectifier current, IKr, dur-
ing the repolarization phase of the cardiac action potential. We have measured
hERG channels in droplet interface bilayers using membrane preparations
made from eukaryotic cells expressing hERG. We find single channel conduc-
tance and reversal potentials consistent with previously published patch clamp
studies as well as the sensitivity of the measured currents to astemizole, a potas-
sium channel blocker, and E-4031, a hERG specific blocker. This sensitivity is
dosage dependent, with IC50 values measured, 91 nM and 12.4 nM for astemi-
zole and E-4031, respectively.
1365-Pos Board B257
Functional Analysis of Concatenated Heterotetrameric hERG1 Channels
Reveals Requirement for Binding to Four Identical Sites to Achieve Full
Activation by hERG1 Agonists
Wei Wu.
Nora Eccles Harrison CVRTI and Dept. of Medicine, University of Utah,
Salt Lake City, UT, USA.
Recently, several small molecule activators of hERG1 Kþ channels have been
discovered, including PD-118057 (PD) and ICA-105574 (ICA). The putative
binding sites for these two activators overlap and are located in a hydrophobic
pocket between the S5 and S6 segments of adjacent hERG1 subunits. Thus,
a homotetrameric hERG1 channel has potentially four identical binding sites.
However, it is unclear whether drug binding to more than one site is required
for full channel activation. Concatenated hERG1 tetramers containing wild-
type and mutant subunits, heterologously expressed in Xenopus oocytes,
were employed to determine the binding stoichiometry of hERG1 agonists.
We previously found single mutation (L646E in S6 or F557L in S5) abolished
the effects of PD and ICA, respectively. Concatenated tetramers were therefore
constructed to contain a variable number (0 to 4) of the mutant subunits.
266a Monday, February 4, 2013PD increases hERG1 current by multiple effects, including a shift of inactiva-
tion to a more positive voltage, slowing of deactivation and an increase in sin-
gle channel open probability. The efficacy of PD was increased in proportion to
the WT:L646E subunit ratio. The Hill coefficient was 1.40 - 1.55 for all the het-
eromeric concatamers, suggesting a weak positive cooperativity for PD bind-
ing. At a fully effective concentration of PD (10mM), each WT binding site
contributes ~20% towards the maximum response of 80% enhancement of
current.
ICA increases hERG1 current by a profound attenuation of inactivation. An in-
crease in the WT:F557L subunit ratio enhanced the agonist activity of ICA
(10mM and 30mM) in a synergistic fashion. For 2WT/2F557L concatenated
channels, synergy required adjacent (as opposed to diagonal) WT subunits.
In summary, four intact binding sites per channel are required to fully activate
hERG1 by PD or ICA.
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Human ether-a-go-go related gene (hERG) channel inhibitors can be trapped in
the channels at rest. The structural peculiarities of hERG blockers that enable
trapping or alternatively resting state dissociation are currently unknown. Prop-
afenone (small molecule, MW 341 g/mol) is efficiently trapped in the closed
hERG channel pore (1). To investigate whether the size of the blocking mole-
cule plays a role in trapping we synthesized bulky propafenone derivatives con-
taining benzoyl and trimethylphenyl side chains, attached by piperazine linkers,
with molecular weights of 500 (Fba212) and 650 g/mol (Fba213) respectively.
hERG channels were expressed in Xenopus laevis oocyte and potassium cur-
rent inhibition was studied using the two - microelectrode voltage clamp
technique.
It was found: first, both compounds are potent hERG blockers with IC50 3.7mM
(Fba212) and 52mM (Fba213). Secondly, channel block by Fba212 and 213 was
prevented by mutations Y652A and F656A as previously shown for propafe-
none. Third, both propafenone derivatives were trapped at rest. To obtain
insights into the molecular mechanism of channel block docking experiments
with Fba212 and Fba213 in closed and open conformation were performed.
Both compounds interact with the propafenone binding site (Y652A and
F656A). Fba213 was found to exceed the size of the closed channel cavity of
our hERG homology model. We conclude that drug trapping in hERG channels
does not necessarily require full closure of the activation gate.
1. Witchel HJ, Dempsey CE, Sessions RB, Perry M, Milnes JT, Hancox JC,
Mitcheson JS.
Mol Pharmacol. 2004 Nov; 66(5):1201-12.
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ICA105574 (3-Nitro-N-(4-phenoxyphenyl)-benzamide) activates hERG1
(Kv11.1) channels by reducing inactivation, but inhibits hEAG1 (Kv10.1)
channels by inducing inactivation. using chimeric ERG-EAG constructs, we
found that the channel-specific response to ICA105574 is mediated by the
pore region (S5-pore helix-S6). Simulated docking of ICA105574 on a molec-
ular model of hEAG1 coupled with alanine mutagenesis indicates that similar
to hERG1, ICA105574 binds to a hydrophobic region confined by the S5/S6/
pore helix of one subunit and S6 of adjacent subunit in hEAG1 channels. Based
on the putative ICA binding site and protein sequence alignment, a triple
mutant of hEAG1 (M431F/M458L/L463M hEAG1) was designed to make
the ICA binding region in hEAG1 homologous to hERG1. ICA inhibited the
triple mutant similar to WT-hEAG1, indicating that the amino acid differences
within the putative ICA binding region do not determine the reciprocal func-
tional response to ICA. A single mutation in S5 (F557L), pore helix (L622C)
or S6 (Y652A) of hERG1 eliminates the activity of ICA on hERG1 (Garg, et
al 2011, Mol. Pharm.). The equivalent mutations in hEAG1 affect inactivation
differentially and result in very different responses to ICA. First, Y464A in-
duced inactivation of hEAG1 channels and this gating was accentuated by
ICA. Second, ICA is a partial agonist of F359L and L434C mutant channels.
We recently proposed a tripartite model of slow inactivation for hEAG1 that
involves interaction of the same three residues. We conclude that ICA bindsto the same site in hEAG1 and hERG1 channels, and that the functional conse-
quences are determined by the underlying (fast or slow) mode of selectivity-
filter mediated inactivation.
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The human ether-a-go-go related gene 1 (hERG1) potassium ion channel is
a key element for the cardiac delayed rectified potassium current IKr and it
plays an important role in the normal repolarization of the action potential.
Diverse types of organic compounds used both in common cardiac and noncar-
diac medications can reduce the IKr and may lead to ventricular arrhythmia.
Therefore, several approved drugs have been withdrawn from the market
because of their effects on QT interval prolongation. Since most of these drugs
have high potency for their principal targets, ‘‘rehabilitation’’ studies for de-
creasing their high hERG1 blocking affinities while keeping them active at
the binding site of their targets may lead re-use of these drugs. For this aim,
a gastroprokinetic agent, cisapride, is studied. Cisapride is withdrawn from
the market because of its high hERG1 blocking affinity. In this study, analyses
of fragment interactions of cisapride at the human A2A adenosine receptor and
hERG1 central cavities is investigated using in silico applications (molecular
docking, molecular dynamics simulations, de novo drug design) and novel
and safer (with low hERG1 blocking affinities) of cisapride derivatives are pro-
posed for their synthesis and their biological tests.
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The human Ether-a-go-go Related Gene (hERG) encodes Kv11.1 and underlies
the rapidly activating delayed rectifier Kþ current in the heart, and loss-of-
function hERG mutations cause the type 2 long QT syndrome (LQT2). The
majority of LQT2-linked missense mutations decrease the trafficking of
Kv11.1. An important finding is drugs that bind to Kv11.1 and block current
(IKv11.1) can correct the trafficking for most of these mutations (pharmacolog-
ical correction). We tested the hypothesis that pharmacological correction in-
creases the trafficking of mutant LQT2 channels from the Endoplasmic
Reticulum (ER). Voltage-clamping and Western blotting experiments of
HEK293 cells expressing the trafficking-deficient LQT2 mutation G601S
showed that pharmacological correction still occurred in cells treated with the
protein synthesis inhibitor cycloheximide. Confocal analyses of HEK293 cells
stably expressing wild type Kv11.1 or G601S showed that G601S is selectively
stored in an intermediate ER compartment with BAP31. The intermediate
BAP31 compartment does not overlap with the perinuclear ER compartment,
transitional ER compartment, or the ER Golgi Intermediate Compartment.
Treating cells in E-4031, a drug that corrects G601S trafficking, decreased
G601S co-localization with intermediate BAP31 compartment and increased
G601S immunostaining at the cell surface membrane. Additional experiments
showed that treating cell in E-4031 for as little as 30 min was sufficient to
caused the pharmacological correction of IKv11.1 for many hours. Together
these data demonstrate that a steady-state subpopulation of LQT2 channels is
stored separately in the BAP31 transitional ER compartment and their func-
tional expression is readily corrected by E-4031 treatment.
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Long QT syndrome type 2 (LQT2) is caused by mutations in the human ether-
a-go-go related gene (hERG). The reinitiation of translation has recently been
reported as a novel pathogenic mechanism of LQT2 by which early PTC mu-
tations generate N-terminally truncated channels with altered gating properties.
We have previously shown that hERG transcripts containing the Q81X muta-
tion were translated at the downstreamM124 codon following premature termi-
nation and generated channels that exhibited increased deactivation kinetics
and decreased resurgent outward current during action potential repolarization.
We have now identified two additional LQT2 nonsense mutations C39X and
C44X that escape nonsense mediated mRNA decay by the reinitiation of trans-
lation. Unlike the Q81X channels, which are expressed at the cell surface,
